TrialBMC cancer2026

Comparative assessment of asparaginase activity, population pharmacokinetics, and safety of biosimilar native Escherichia coli and pegylated asparaginase in children with newly diagnosed acute lymphoblastic leukemia: a pharmacometrics-based randomized clinical trial.

Sujitha Sethuramalingam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.